Security key
00974H104
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA)
CUSIP: 00974H104
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 54,965,124
- Total 13F shares
- 16,048,557
- Share change
- -13,395
- Total reported value
- $74,626,912
- Put/Call ratio
- 4.3%
- Price per share
- $4.65
- Number of holders
- 60
- Value change
- -$4,377,853
- Number of buys
- 37
- Number of sells
- 29
Report period
Q3 2023
Institutions
60
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 00974H104
Recent filing periods:
Top shareholders of AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q3 2023
As of 30 Sep 2023,
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,048,557 shares.
The largest 10 holders included
Blue Water Life Science Advisors, LP, Polar Capital Holdings Plc, BlackRock Inc., VANGUARD GROUP INC, Kent Lake Capital LLC, Board of Trustees of The Leland Stanford Junior University, Uniplan Investment Counsel, Inc., MILLENNIUM MANAGEMENT LLC, Parkman Healthcare Partners LLC, and SVB WEALTH LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
72
Q3 2023 holders
60
Holder diff
-12
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.